Mathematical modeling as accounting: Predicting the fate of serum proteins and therapeutic monoclonal antibodies

被引:9
|
作者
Gurbaxani, Brian [1 ]
机构
[1] Ctr Dis Control & Prevent, Viral Exanthems & Herpes Virus Branch, Coordinating Ctr Infect Dis, Atlanta, GA 30333 USA
关键词
FcRn; albumin; antibodies; half life; mathematical modeling;
D O I
10.1016/j.clim.2006.10.001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
This article reviews current efforts to mathematically model the half lives of serum proteins, especially antibodies. While it is recognized that the neonatal Fc receptor, FcRn, is necessary for longer serum persistence of certain proteins, particularly the high abundance IgGs and albumin, it is not clear that it is sufficient to completely determine the half lives of these proteins. More specifically, it is unclear why the high avidity (bivalent), high affinity FcRn-IgG interaction, with half saturation in the 10 to 100 nM range (at endosomal pH according to the currently proposed mechanism), would result in a salvage mechanism that saturates at serum concentrations in the 10 to 100 mg/ml range a discrepancy of 4 to 5 orders of magnitude. Alternative explanations include the proposal that the very tow affinity binding between FcRn and IgG at blood pH is also relevant to the salvage mechanism, and that factors in addition to FcRn binding modulate the maintenance and clearance of IgG from serum. Published by Elsevier Inc.
引用
收藏
页码:121 / 124
页数:4
相关论文
共 50 条
  • [1] Drug interaction studies of therapeutic proteins or monoclonal antibodies
    Mahmood, Iftekhar
    Green, Martin David
    JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 47 (12): : 1540 - 1554
  • [2] The Fate and Function of Therapeutic Antiaddiction Monoclonal Antibodies across the Reproductive Cycle of Rats
    Hubbard, Jonathan J.
    Laurenzana, Elizabeth M.
    Williams, D. Keith
    Gentry, W. Brooks
    Owens, S. Michael
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2011, 336 (02): : 414 - 422
  • [3] Predicting multimodal chromatography of therapeutic antibodies using multiscale modeling
    Hess, Rudger
    Faessler, Jan
    Yun, Doil
    Mama, Ahmed
    Saleh, David
    Grosch, Jan-Hendrik
    Wang, Gang
    Schwab, Thomas
    Hubbuch, Jurgen
    JOURNAL OF CHROMATOGRAPHY A, 2024, 1718
  • [4] Pharmacokinetic Modeling and Predictive Performance: Practical Considerations for Therapeutic Monoclonal Antibodies
    Chen, Yang
    Li, Joshua
    Li, Derry
    Hu, Chuanpu
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2021, 46 (05) : 595 - 600
  • [5] Pharmacokinetic Modeling and Predictive Performance: Practical Considerations for Therapeutic Monoclonal Antibodies
    Yang Chen
    Joshua Li
    Derry Li
    Chuanpu Hu
    European Journal of Drug Metabolism and Pharmacokinetics, 2021, 46 : 595 - 600
  • [6] Image-guided mathematical modeling for pharmacological evaluation of nanomaterials and monoclonal antibodies
    Dogra, Prashant
    Butner, Joseph D.
    Nizzero, Sara
    Ramirez, Javier Ruiz
    Noureddine, Achraf
    Pelaez, Maria J.
    Elganainy, Dalia
    Yang, Zhen
    Le, Anh-Dung
    Goel, Shreya
    Leong, Hon S.
    Koay, Eugene J.
    Brinker, C. Jeffrey
    Cristini, Vittorio
    Wang, Zhihui
    WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY, 2020, 12 (05)
  • [7] Platform development strategy for glycoengineered Pichia for the production of monoclonal antibodies and therapeutic proteins
    Pollard, David J.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 241
  • [8] INDUSTRIAL-PRODUCTION OF MONOCLONAL-ANTIBODIES AND THERAPEUTIC PROTEINS BY DIALYSIS FERMENTATION
    COMER, MJ
    KEARNS, MJ
    WAHL, J
    MUNSTER, M
    LORENZ, T
    SZPERALSKI, B
    KOCH, S
    BEHRENDT, U
    BRUNNER, H
    CYTOTECHNOLOGY, 1990, 3 (03) : 295 - 299
  • [9] Pharmacokinetics and concentration-effect relationships of therapeutic monoclonal antibodies and fusion proteins
    Ternant, D
    Paintaud, G
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2005, 5 : S37 - S47
  • [10] A novel approach to characterize host cell proteins associated with therapeutic monoclonal antibodies
    Thomson, Andrew S.
    Mai, Shing
    Byrne, Michael P.
    BIOTECHNOLOGY AND BIOENGINEERING, 2017, 114 (06) : 1208 - 1214